Linked Life Data

2423256

Source:http://linkedlifedata.com/resource/pubmed/id/2423256

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1986-6-30
pubmed:abstractText
Inosine pranobex-BAN injected intraperitoneally at a daily dose of 500 mg/kg for 15 days into young Sprague-Dawley rats, beginning 24 hours after the implantation of Yoshida ascites tumor cells and the injection of cell-free ascites fluid from the same neoplasia, increased the resistance to the tumor in both cases. This antitumor activity of the drug was mediated by its action on cellular immunity of the host. In our model we considered the role of macrophages.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0392-906X
pubmed:author
pubmed:issnType
Print
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
128-33
pubmed:dateRevised
2003-11-14
pubmed:meshHeading
pubmed:year
1986
pubmed:articleTitle
Inosine pranobex-BAN increases the resistance to the challenge with cells or cell-free fluid from Yoshida ascites tumor.
pubmed:publicationType
Journal Article